Characterization of a broadly reactive monoclonal antibody against norovirus genogroups I and II: Recognition of a novel conformational epitope

Journal of Virology

Volumn 81, Issue 22, 2007, Pages 12298-12306

  Shiota, Tomoyuki ^a   Okame, Michio ^a   Takanashi, Sayaka ^a   Khamrin, Pattara ^a   Takagi, Makiko ^a   Satou, Kenji ^b   Masuoka, Yuichi ^b   Yagyu, Fumihiro ^a   Shimizu, Yuko ^a   Kohno, Hideki ^c   Mizuguchi, Masashi ^a   Okitsu, Shoko ^a   Ushijima, Hiroshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Immuno Probe Co Ltd   (Japan)

^c NIHON UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 14 1; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ANTIBODY SPECIFICITY; ANTIGEN SPECIFICITY; ANTIGENICITY; ARTICLE; BINDING AFFINITY; CALICIVIRUS; CARBOXY TERMINAL SEQUENCE; CONFORMATIONAL TRANSITION; CROSS REACTION; GENE INSERTION; GENETIC CONSERVATION; GENOTYPE; IMMUNE RESPONSE; IMMUNOCHEMISTRY; IMMUNOCHROMATOGRAPHY; NONHUMAN; NOROVIRUS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRAL GASTROENTERITIS; VIRUS MORPHOLOGY; VIRUS MUTATION; VIRUS PARTICLE; VIRUS TYPING;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; CAPSID; CROSS REACTIONS; EPITOPE MAPPING; EPITOPES; HUMANS; MOLECULAR SEQUENCE DATA; NOROVIRUS; POINT MUTATION; PROTEIN CONFORMATION;

CALICIVIRIDAE; NOROVIRUS;

EID: 36049040750     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00891-07     Document Type: Article

References (47)

1. Atmar, R. L., and M. K. Estes. 2006. The epidemiologic and clinical importance of norovirus infection. Gastroenterol. Clin. N. Am. 35:275-290.
2. Ausar, S. F., T. R. Foubert, M. H. Hudson, T. S. Vedvick, and C. R. Middaugh. 2006. Conformational stability and disassembly of Norwalk virus-like particles. Effect of pH and temperature. J. Biol. Chem. 281:19478-19488.
3. Batten, C. A., I. N. Clarke, S. L. Kempster, S. L. Oliver, J. C. Bridger, and P. R. Lambden. 2006. Characterization of a cross-reactive linear epitope in human genogroup I and bovine genogroup III norovirus capsid proteins. Virology 356:179-187.
4. Cao, J., N. Sullivan, E. Desjardin, C. Parolin, J. Robinson, R. Wyatt, and J. Sodroski. 1997. Replication and neutralization of human immunodeficiency virus type 1 lacking the V1 and V2 variable loops of the gp120 envelope glycoprotein. J. Virol. 71:9808-9812.
5. Chakravarty, S., A. M. Hutson, M. K. Estes, and B. V. Prasad. 2005. Evolutionary trace residues in noroviruses: importance in receptor binding, antigenicity, virion assembly, and strain diversity. J. Virol. 79:554-568.
6. Chen, R., J. D. Neill, M. K. Estes, and B. V. Prasad. 2006. X-ray structure of a native calicivirus: structural insights into antigenic diversity and host specificity. Proc. Natl. Acad. Sci. USA 103:8048-8053.
7. Chen, R., J. D. Neill, J. S. Noel, A. M. Hutson, R. I. Glass, M. K. Estes, and B. V. Prasad. 2004. Inter- and intragenus structural variations in caliciviruses and their functional implications. J. Virol. 78:6469-6479.
8. SF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation. J. Virol. 73:5294-5300.
9. Geissler, K., K. Schneider, and U. Truyen. 2002. Mapping neutralizing and non-neutralizing epitopes on the capsid protein of feline calicivirus. J. Vet. Med. B Infect. Dis. Vet. Public Health 49:55-60.
10. Geysen, H. M., T. J. Mason, and S. J. Rodda. 1988. Cognitive features of continuous antigenic determinants. J. Mol. Recognit. 1:32-41.
11. Glass, R. I., J. Noel, T. Ando, R. Fankhauser, G. Belliot, A. Mounts, U. D. Parashar, J. S. Bresee, and S. S. Monroe. 2000. The epidemiology of enteric caliciviruses from humans: a reassessment using new diagnostics. J. Infect. Dis. 181(Suppl. 2):S254-S261.
12. Green, K. Y., J. F. Lew, X. Jiang, A. Z. Kapikian, and M. K. Estes. 1993. Comparison of the reactivities of baculovirus-expressed recombinant Norwalk virus capsid antigen with those of the native Norwalk virus antigen in serologic assays and some epidemiologic observations. J. Clin. Microbiol. 31:2185-2191.
13. Hale, A. D., S. E. Crawford, M. Ciarlet, J. Green, C. Gallimore, D. W. Brown, X. Jiang, and M. K. Estes. 1999. Expression and self-assembly of Grimsby virus: antigenic distinction from Norwalk and Mexico viruses. Clin. Diagn. Lab. Immunol. 6:142-145.
14. Hardy, M. E., T. N. Tanaka, N. Kitamoto, L. J. White, J. M. Ball, X. Jiang, and M. K. Estes. 1996. Antigenic mapping of the recombinant Norwalk virus capsid protein using monoclonal antibodies. Virology 217:252-261.
15. Hutson, A. M., R. L. Atmar, D. M. Marcus, and M. K. Estes. 2003. Norwalk virus-like particle hemagglutination by binding to H histo-blood group antigens. J. Virol. 77:405-415.
16. Jiang, X., M. Wang, D. Y. Graham, and M. K. Estes. 1992. Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J. Virol. 66:6527-6532.
17. Kageyama, T., M. Shinohara, K. Uchida, S. Fukushi, F. B. Hoshino, S. Kojima, R. Takai, T. Oka, N. Takeda, and K. Katayama. 2004. Coexistence of multiple genotypes, including newly identified genotypes, in outbreaks of gastroenteritis due to norovirus in Japan. J. Clin. Microbiol. 42:2988-2995.
18. Kamata, K., K. Shinozaki, M. Okada, Y. Seto, S. Kobayashi, K. Sakae, M. Oseto, K. Natori, H. Shirato-Horikoshi, K. Katayama, T. Tanaka, N. Takeda, and K. Taniguchi. 2005. Expression and antigenicity of virus-like particles of norovirus and their application for detection of noroviruses in stool samples. J. Med. Virol. 76:129-136.
19. Karst, S. M., C. E. Wobus, M. Lay, J. Davidson, and H. W. Virgin IV. 2003. STAT1-dependent innate immunity to a Norwalk-like virus. Science 299:1575-1578.
20. Kitamoto, N., T. Tanaka, K. Natori, N. Takeda, S. Nakata, X. Jiang, and M. K. Estes. 2002. Cross-reactivity among several recombinant calicivirus virus-like particles (VLPs) with monoclonal antibodies obtained from mice immunized orally with one type of VLP. J. Clin. Microbiol. 40:2459-2465.
21. Kobayashi, S., K. Sakae, Y. Suzuki, K. Shinozaki, M. Okada, H. Ishiko, K. Kamata, K. Suzuki, K. Natori, T. Miyamura, and N. Takeda. 2000. Molecular cloning, expression, and antigenicity of Seto virus belonging to genogroup 1 Norwalk-like viruses. J. Clin. Microbiol. 38:3492-3494.
22. Kohler, G., and C. Milstein. 1975. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495-497.
23. Krachmarov, C. P., W. J. Honnen, S. C. Kayman, M. K. Gorny, S. Zolla-Pazner, and A. Pinter. 2006. Factors determining the breadth and potency of neutralization by V3-specific human monoclonal antibodies derived from subjects infected with clade A or clade B strains of human immunodeficiency virus type 1. J. Virol. 80:7127-7135.
24. Laemmli, U. K., F. Beguin, and G. Gujer-Kellenberger. 1970. A factor preventing the major head protein of bacteriophage T4 from random aggregation. J. Mol. Biol. 47:69-85.
25. Lochridge, V. P., K. L. Jutila, J. W. Graff, and M. E. Hardy. 2005. Epitopes in the P2 domain of norovirus VP1 recognized by monoclonal antibodies that block cell interactions. J. Gen. Virol. 86:2799-2806.
26. Ly, A., and L. Stamatatos. 2000. V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies. J. Virol. 74:6769-6776.
27. Matsuura, Y., Y. Tohya, M. Mochizuki, K. Takase, and T. Sugimura. 2001. Identification of conformational neutralizing epitopes on the capsid protein of canine calicivirus. J. Gen. Virol. 82:1695-1702.
28. Nguyen, T. A., P. Khamrin, S. Takanashi, L. P. Hoang, D. L. Pham, T. K. Hoang, K. Satou, Y. Masuoka, S. Okitsu, and H. Ushijima. 2007. Evaluation of immunochromatography tests for detection of rotavirus and norovirus among Vietnamese children with acute gastroenteritis and the emergence of a novel norovirus GII.4 variant. J. Trop. Pediatr. 53:264-269.
29. Notredame, C., D. G. Higgins, and J. Heringa. 2000. T-Coffee: a novel method for fast and accurate multiple sequence alignment. J. Mol. Biol. 302:205-217.
30. Okada, M., T. Ogawa, I. Kaiho, and K. Shinozaki. 2005. Genetic analysis of noroviruses in Chiba Prefecture, Japan, between 1999 and 2004. J. Clin. Microbiol. 43:4391-4401.
31. Okame, M., H. Yan, S. Akihara, S. Okitsu, H. Tani, Y. Matsuura, and H. Ushijima. 2003. Evaluation of a newly developed immunochromatographic method for detection of norovirus. Kansenshogaku Zasshi 77:637-639.
32. Okitsu-Negishi, S., M. Okame, Y. Shimizu, T. G. Phan, T. Tomaru, S. Kamijo, T. Sato, F. Yagyu, W. E. Muller, and H. Ushijima. 2006. Detection of norovirus antigens from recombinant virus-like particles and stool samples by a commercial norovirus enzyme-linked immunosorbent assay kit. J. Clin. Microbiol. 44:3784-3786.
33. Oliver, S. L., E. Asobayire, A. M. Dastjerdi, and J. C. Bridger. 2006. Genomic characterization of the unclassified bovine enteric virus Newbury agent-1 (Newburyl) endorses a new genus in the family Caliciviridae. Virology 350:240-250.
34. Oliver, S. L., C. A. Batten, Y. Deng, M. Elschner, P. Otto, A. Charpilienne, I. N. Clarke, J. C. Bridger, and P. R. Lambden. 2006. Genotype 1 and genotype 2 bovine noroviruses are antigenically distinct but share a cross-reactive epitope with human noroviruses. J. Clin. Microbiol. 44:992-998.
35. Parker, T. D., N. Kitamoto, T. Tanaka, A. M. Hutson, and M. K. Estes. 2005. Identification of genogroup I and genogroup II broadly reactive epitopes on the norovirus capsid. J. Virol. 79:7402-7409.
36. Pinter, A., W. J. Honnen, Y. He, M. K. Gorny, S. Zolla-Pazner, and S. C. Kayman. 2004. The V1/V2 domain of gp120 is a global regulator of the sensitivity of primary human immunodeficiency virus type 1 isolates to neutralization by antibodies commonly induced upon infection. J. Virol. 78:5205-5215.
37. Prasad, B. V., M. E. Hardy, T. Dokland, J. Bella, M. G. Rossmann, and M. K. Estes. 1999. X-ray crystallographic structure of the Norwalk virus capsid. Science 286:287-290.
38. Schwede, T., J. Kopp, N. Guex, and M. C. Peitsch. 2003. SWISS-MODEL: an automated protein homology-modeling server. Nucleic Acids Res. 31:3381-3385.
39. Tanaka, T., N. Kitamoto, X. Jiang, and M. K. Estes. 2006. High efficiency cross-reactive monoclonal antibody production by oral immunization with recombinant Norwalk virus-like particles. Microbiol. Immunol. 50:883-888.
40. Thompson, J. D., T. J. Gibson, F. Plewniak, F. Jeanmougin, and D. G. Higgins. 1997. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 25:4876-4882.
41. Tohya, Y., K. Masuoka, E. Takahashi, and T. Mikami. 1991. Neutralizing epitopes of feline calicivirus. Arch. Virol. 117:173-181.
42. Tohya, Y., Y. Taniguchi, M. Tsubakimoto, E. Takahashi, and T. Mikami. 1990. Preparation and characterization of neutralizing monoclonal antibodies to feline calicivirus. Nippon Juigaku Zasshi 52:251-256.
43. Tohya, Y., N. Yokoyama, K. Maeda, Y. Kawaguchi, and T. Mikami. 1997. Mapping of antigenic sites involved in neutralization on the capsid protein of feline calicivirus. J. Gen. Virol. 78:303-305.
44. Wei, X., J. M. Decker, S. Wang, H. Hui, J. C. Kappes, X. Wu, J. F. Salazar-Gonzalez, M. G. Salazar, J. M. Kilby, M. S. Saag, N. L. Komarova, M. A. Nowak, B. H. Hahn, P. D. Kwong, and G. M. Shaw. 2003. Antibody neutralization and escape by HIV-1. Nature 422:307-312.
45. White, L. J., M. E. Hardy, and M. K. Estes. 1997. Biochemical characterization of a smaller form of recombinant Norwalk virus capsids assembled in insect cells. J. Virol. 71:8066-8072.
46. Yoda, T., Y. Suzuki, Y. Terano, K. Yamazaki, N. Sakon, T. Kuzuguchi, H. Oda, and T. Tsukamoto. 2003. Precise characterization of norovirus (Norwalk-like virus)-specific monoclonal antibodies with broad reactivity. J. Clin. Microbiol. 41:2367-2371.
47. Yoda, T., Y. Terano, Y. Suzuki, K. Yamazaki, I. Oishi, T. Kuzuguchi, H. Kawamoto, E. Utagawa, K. Takino, H. Oda, and T. Shibata. 2001. Characterization of Norwalk virus GI specific monoclonal antibodies generated against Escherichia coli expressed capsid protein and the reactivity of two broadly reactive monoclonal antibodies generated against GII capsid towards GI recombinant fragments. BMC Microbiol. 1:24.